Apogee Therapeutics Inc. Financials

APGE

All currency values in $ millions unless otherwise noted

Income Statement	DEC 2025	DEC 2024 ~2.2:1 split	DEC 2023 ~10.2:1 split	DEC 2022
General & Administrative	$71	$49	$25	$3
Research & Development	$215	$168	$68	$28
Total Operating Expenses	$286	$217	$93	$31
Operating Income	-$286	-$217	-$93	-$31
Non-Operating
Net Interest Expense	$30	$35	$9	$0
Other Non-Operating Income (Expense)	$0	$0	$0	-$9
EBT (Earnings Before Tax)	-$256	-$182	-$84	–
Income Tax Expense	$0	$0	$0	–
Net Income
Net Income	-$256	-$182	-$84	-$40
EPS (Basic)	-$4.22	-$3.30	-$3.36	-$16.16
EPS (Diluted)	-$4.22	-$3.30	-$3.36	-$16.16
Weighted Avg Shares (Basic)	60.7M	55.2M	25.0M	2.5M
Weighted Avg Shares (Diluted)	60.7M	55.2M	25.0M	2.5M
Shares Outstanding	60.7M	55.2M	25.0M	2.5M

Apogee Therapeutics (APGE) financials: revenue, profit and margins

Apogee Therapeutics (APGE) generated about n/a in revenue and -$294 million in net income over the trailing twelve months. Figures are from SEC filings; this is analysis, not investment advice.

Frequently asked

Is Apogee Therapeutics profitable?+

Apogee Therapeutics reported about -$294 million in net loss over the trailing twelve months. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

More on APGE: Overview · Quality scorecard · DCF valuation · Dividend safety

How the market compares: How many US companies are profitable

SourceFinancial statements computed from the 10-Q filed 10 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 11 Aug 2026. How this is calculated.

Fiscal year ends Dec.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with APGE

CompareIntrinsic value

ENTXEntera Bio Ltd.

$3.11+1.97%20

ELOXEloxx Pharmaceuticals, Inc.

$12.74-1.39%20

CMPXCompass Therapeutics Inc.

$0.76+1.33%10

SABSSab Biotherapeutics Inc.

$3.18+1.92%19

ARTVArtiva Biotherapeutics Inc.

$4.22+0.48%10

GLUEMonte Rosa Therapeutics, Inc.

$10.82+3.94%10

ALGSAligos Therapeutics Inc.

$5.02+5.68%10

SRRKScholar Rock Holding Corporation

$46.09+4.80%10

Held by ETFs

APGE is in 36 US ETFs. The largest of them, with APGE's weight in each:

Spot a number that looks wrong? Check it in APGE's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing APGE

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.